Search - tctmd.com

Displaying 521 - 540 of 837

Sort: Relevancy | Date

News Daily News

Los Balones Recubiertos de Fármacos son Más Aptos para el Manejo de la Reestenosis Intra-Stent en SMD que en SLF

Caitlin E. Cox

August 17, 2016

News Daily News

Drug-Coated Balloons Best Suited for In-Stent Restenosis in BMS, not DES

Caitlin E. Cox

August 17, 2016

News Daily News

TCTMD’s Top 10 Most Popular Stories for July 2016

Shelley Wood

July 28, 2016

News Daily News

PLATFORM: FFRCT-Guided Strategy in Suspected CAD ‘Durable’ Out to 1 Year

Michael O'Riordan

July 27, 2016

News Daily News

PLATFORM: Ante Sospecha de EAC la Estrategia de Guiado mediante FFRTC ‘Tiene una Duración’ de 1 Año

Michael O'Riordan

July 27, 2016

News Daily News

需要手术的支架患者的抗血小板治疗：意大利经验提供了方向

Michael O'Riordan

July 20, 2016

News Daily News

Tratamiento Antiplaquetario en Pacientes con Stents que Necesitan Cirugía: La Experiencia de Italia Marca el Camino a Seguir

Michael O'Riordan

July 20, 2016

News Daily News

Antiplatelet Therapy in Stented Patients Needing Surgery: Italian Experience Provides Direction

Michael O'Riordan

July 20, 2016

News Industry News

Tallahassee Memorial HealthCare Becomes First Hospital in Florida to Offer and Deploy First-of-Its-Kind Naturally Dissolving Heart Stent

July 14, 2016

News Daily News

Now You See It: FDA Approves Absorb Bioresorbable Scaffold

Michael O'Riordan

July 05, 2016

Podcast Heart Sounds

TCTMD’s Top 10 Most Popular Stories for June 2016

Shelley Wood

July 01, 2016

Presentation CCVVC 2016

Optimal Duration of DAPT: Update on DAPT Guidelines

Presenter: Roxana Mehran

June 16, 2016

News Daily News

Survey of Interventional Cardiologists With Absorb BVS Expertise Gives Snapshot of Attitudes, Usage

Michael O'Riordan

June 14, 2016

Podcast Heart Sounds

Reassuring Registry Data Suggest Scaffold Thrombosis Rates with BVS Declining

Michael O'Riordan

May 17, 2016

News Conference News EuroPCR 2016

Not Necessarily PERFECT, but Drug-Eluting Balloon Shows Promise for Erectile Dysfunction

Yael L. Maxwell

May 17, 2016

News Conference News EuroPCR 2016

Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS

Michael O'Riordan

May 17, 2016

News Daily News

Everolimus Stent Better Than Paclitaxel Stent in Diabetic Patients, Even Those Requiring Insulin: TUXEDO Analysis

Michael O'Riordan

April 25, 2016

News Daily News

Análisis del TUXEDO: Los Stents de Everolimus son Mejores que los de Paclitaxel en Pacientes Diabéticos, Incluso en Insulinodependientes

Michael O'Riordan

April 25, 2016

Advertisement

Los Balones Recubiertos de Fármacos son Más Aptos para el Manejo de la Reestenosis Intra-Stent en SMD que en SLF

Drug-Coated Balloons Best Suited for In-Stent Restenosis in BMS, not DES

TCTMD’s Top 10 Most Popular Stories for July 2016

PLATFORM: FFRCT-Guided Strategy in Suspected CAD ‘Durable’ Out to 1 Year

PLATFORM: Ante Sospecha de EAC la Estrategia de Guiado mediante FFRTC ‘Tiene una Duración’ de 1 Año

需要手术的支架患者的抗血小板治疗：意大利经验提供了方向

Tratamiento Antiplaquetario en Pacientes con Stents que Necesitan Cirugía: La Experiencia de Italia Marca el Camino a Seguir

Antiplatelet Therapy in Stented Patients Needing Surgery: Italian Experience Provides Direction

Tallahassee Memorial HealthCare Becomes First Hospital in Florida to Offer and Deploy First-of-Its-Kind Naturally Dissolving Heart Stent

Now You See It: FDA Approves Absorb Bioresorbable Scaffold

Top Stories in Cardiology: June 2016

TCTMD’s Top 10 Most Popular Stories for June 2016

Optimal Duration of DAPT: Update on DAPT Guidelines

Survey of Interventional Cardiologists With Absorb BVS Expertise Gives Snapshot of Attitudes, Usage

Top Stories in Cardiology: May 2016

Reassuring Registry Data Suggest Scaffold Thrombosis Rates with BVS Declining

Not Necessarily PERFECT, but Drug-Eluting Balloon Shows Promise for Erectile Dysfunction

Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS

Everolimus Stent Better Than Paclitaxel Stent in Diabetic Patients, Even Those Requiring Insulin: TUXEDO Analysis

Análisis del TUXEDO: Los Stents de Everolimus son Mejores que los de Paclitaxel en Pacientes Diabéticos, Incluso en Insulinodependientes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content